학술논문
Peripheral Nerve Safety of Nerve Growth Factor Inhibition by Tanezumab: Pooled Analyses of Phase III Clinical Studies in Over 5000 Patients with Osteoarthritis
Document Type
Article
Author
Source
In: Clinical Drug Investigation . (Clinical Drug Investigation, July 2023, 43(7):551-563)
Subject
Language
English
ISSN
11791918
11732563
11732563